Of note, 4 (2%) SBTs had mutations in both BRAF and KRAS. For these, tumor cells were enriched by laser-capture microdissection and digital droplet PCR (ddPCR) was repeated to obtain mutant allele frequencies (MAF) within the tumor cell population. The gene discussed is BRAF; the disease is neoplasm.